Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

Search Results

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

Sponsored by The PERT Consortium™

evt | Article | July 2019 Supplement

Catheter-Based Therapy: Are We Making Progress and Is the Game Changing?

By Thomas M. Todoran, MD, MSc; Wissam A. Jaber, MD; and John M. Moriarty, MD

evt | Article | April 2024

Acute Pulmonary Embolism Presenting as Hypotension and Hypoxic Respiratory Failure

A discussion of percutaneous pulmonary embolism management.

By Bryan Kindya, MD, and Wissam A. Jaber, MD

evt | Article | January 2026

Understanding the Endpoint: Deep Dives on Modern PE Outcomes

Reflections on defining pulmonary embolism outcomes in today’s evolving practice, including most meaningful endpoints, pros and cons of RV/LV ratio and composite endpoints, and patient and payer priorities.

With Wissam A. Jaber, MD; Soophia Naydenov, MD, FCCP; and Peter P. Monteleone, MD, FACC, FSCAI

Sponsored by The PERT Consortium™

evt | Article | July 2022 Supplement

The PERT Consortium™ PE Registry and Research Committee: Updates and Future Directions

The development of a real-world pulmonary embolism registry and research committee to inform providers on best practices, establish a mechanism for initiating and funding investigator-led projects, and provide a platform for prospective clinical research trials.

By Amir Darki, MD, MSc, and Wissam A. Jaber, MD

Advertisement

Sponsored by Inari Medical

evt | Article | August 2018

Emerging Tools for Lytic-Free, Single-Session Treatment of Venous Thromboembolic Disease

The ClotTriever Outcomes (CLOUT) registry principal investigators share their current DVT practices and thoughts on the new study, and DVT and PE case reports are presented using the Inari Medical ClotTriever and FlowTriever Systems.

With Robert E. Beasley, MD, FSIR, FSCAI; William Marston, MD; Suman Annambhotla, MD; and Wissam A. Jaber, MD

evt | News | October 29, 2024

PEERLESS RCT Compares Large-Bore Mechanical Thrombectomy to CDT for Intermediate-Risk PE

October 29, 2024—Findings were presented from the international PEERLESS randomized controlled trial comparing patient outcomes after treatment with large-bore mechanical thrombectomy (LBMT) versus catheter-directed thrombolysis (CDT) for intermediate-risk pulmonary embolism (PE).

evt | Article | April 2024

Navigating Complex Cases

By Kevin Rogers, MD

Sponsored by Inari Medical

evt | Article | July 2020

Reversing the Death Spiral: FlowTriever Thrombectomy for High-Risk PE

A panel of experts shares their high-risk PE treatment strategies and an update on the FLAME study, plus case reports of FlowTriever thrombectomy use in high-risk patients after cardiac arrest.

With James Horowitz, MD, FACC; Mitchell J. Silver, DO, FACC, FSVM, RPVI; Catalin Toma, MD; Pavan Khanna, MD; Mitchell Weinberg, MD; and Andrew Galmer, DO

evt | Article | January 2026

Advancing PE Management

By Kenneth Rosenfield, MD, MHCDS

evt | News | July 30, 2024

Thrombolex and Aidoc Form Strategic Partnership for RAPID-PE Registry Enrollment

July 30, 2024—Thrombolex, Inc. and Aidoc recently announced a strategic partnership focused on the treatment of acute pulmonary embolism (PE).

evt | News | October 28, 2025

Thrombolex Bashir Catheter for Acute PE Studied in Interim Analysis of RAPID-PE

October 28, 2025—Thrombolex, Inc. announced findings from a prespecified interim analysis from the first 50 patients in the postmarket RAPID-PE study.

Sponsored by Inari Medical

evt | Article | November 2018

Novel Mechanical Thrombectomy Tools for Venous Thromboembolism

Dr. Antonious Attallah and Dr. Herman Kado report on recent FlowTriever and ClotTriever PE and DVT cases, and extracted clot images are presented from recent procedures performed across the United States.

With Antonious Attallah, MD, FACC, FSCAI, and Herman Kado, MD, FACC, FSCAI, RPVI

evt | News | October 18, 2021

Inari Medical’s FlowTriever Will Be Evaluated for Intermediate-High Risk PE in PEERLESS RCT

October 18, 2021—Inari Medical, Inc. announced planned enrollment of the PEERLESS randomized controlled trial (RCT) comparing the clinical outcomes of patients with intermediate-high risk pulmonary embolism (PE) treated with the company’s FlowTriever system versus catheter-directed thrombolysis (CDT).

evt | News | May 20, 2018

Inari Medical's FlowTriever System Cleared by FDA to Treat Pulmonary Embolism

May 21, 2018—Inari Medical, Inc. announced that its FlowTriever thrombectomy system has received US Food and Drug Administration 510(k) clearance for the treatment of pulmonary embolism (PE).

evt | News | October 23, 2024

Thrombolex Begins Enrollment in RAPID-PE Postmarket Study of Bashir Catheter

October 23, 2024—Thrombolex, Inc. announced the commencement of enrollment in the RAPID-PE study, which uses the company’s Bashir endovascular catheter for treatment of acute pulmonary embolism (PE).

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button